News
$Affimed NV(AFMD.US$ Affimed Says FDA Granted Fast Track Designation To Combination Of Its Innate Cell Engager AFM24 With Atezolizumab For EGFR Wild-Type Non-Small Cell Lung Cancer
Benzinga· 2 mins ago
Benzinga· 2 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
RideTheTide : Isn’t this a good news? The stock goes down instead
Trytosaveabit OP RideTheTide : Yes it is good news! The volume is still super low. Will have to see how it does at market open! You got to remember that only a small fraction of traders can /do actually trade in PM! GL